Trial: 201910148

A Phase 2, Single Arm Study of Atezolizumab + Bevacizumab in women with advanced, recurrent or persistent endometrial cancer

Phase

II (Cancer Control) (Cancer Prevention)

Principal Investigator

McCourt, Carolyn

Disease Site

Corpus Uteri

Learn more about this study at: clinicaltrials.gov